Sue Currie, PhD

Virion Therapeutics
Newark, Delaware, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 2320 - Novel checkpoint modifier lowers T cell activation threshold and enhances and broadens vaccine-induced responses to chronic viral infections

  Saturday, October 22, 2022
  2:15 PM – 2:30 PM US ET